NSRX (NSRX)
2.93
-0.31 (9.57%)
Upcoming Events
Latest Headlines
Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis
June 1, 2026 8:00 AM - Globe NewsWire
Form S-8 Nasus Pharma Ltd
May 26, 2026 5:20 PM - SEC Filing
Form SCHEDULE 13G Nasus Pharma Ltd Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 6:36 AM - SEC Filing
Nasus Pharma to Participate in Upcoming Investor Conferences
May 1, 2026 9:14 AM - StreetInsider
Nasus Pharma to Participate in Upcoming Investor Conferences
May 1, 2026 9:14 AM - Globe NewsWire
Form 4 Nasus Pharma Ltd For: Apr 22 Filed by: Teleman Dan Benjamin
April 22, 2026 9:44 PM - SEC Filing
RedChip's Biotech Virtual Investor Conference Replays Now Available
April 21, 2026 3:00 PM - StreetInsider
Form SCHEDULE 13G Nasus Pharma Ltd Filed by: Funicular Funds, LP
April 7, 2026 5:15 PM - SEC Filing
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
April 7, 2026 11:00 AM - StreetInsider
Form 4 Nasus Pharma Ltd For: Mar 31 Filed by: Teleman Dan Benjamin
April 1, 2026 7:32 AM - SEC Filing
Form EFFECT Nasus Pharma Ltd
April 1, 2026 6:07 AM - SEC Filing
Form 3 Nasus Pharma Ltd For: Mar 18 Filed by: Rubin Eyal
March 27, 2026 9:38 PM - SEC Filing
Form 3 Nasus Pharma Ltd For: Mar 18 Filed by: Teleman Dan Benjamin
March 27, 2026 8:57 PM - SEC Filing
Form 3 Nasus Pharma Ltd For: Mar 18 Filed by: Silberman David
March 27, 2026 8:57 PM - SEC Filing
Form 3 Nasus Pharma Ltd For: Mar 18 Filed by: Israel Isaac
March 27, 2026 8:57 PM - SEC Filing
Form 3 Nasus Pharma Ltd For: Mar 18 Filed by: Gilboa Udi
March 27, 2026 8:57 PM - SEC Filing
Form 3 Nasus Pharma Ltd For: Mar 18 Filed by: Megiddo Dalia
March 27, 2026 8:57 PM - SEC Filing
Form 3 Nasus Pharma Ltd For: Mar 18 Filed by: Shacham Sharon
March 27, 2026 8:57 PM - SEC Filing
Form 3 Nasus Pharma Ltd For: Mar 18 Filed by: Hershman Ronnie
March 27, 2026 8:57 PM - SEC Filing
Form POS AM Nasus Pharma Ltd
March 27, 2026 5:24 PM - SEC Filing
Nasus Pharma Ltd (NSRX) PT Lowered to $18 at Citizens: NS002 Likely Best-in-Class
March 26, 2026 4:44 AM - StreetInsider
Form 6-K Nasus Pharma Ltd For: Mar 25
March 25, 2026 4:05 PM - SEC Filing
Form 20-F Nasus Pharma Ltd For: Dec 31
March 25, 2026 9:15 AM - SEC Filing
Nasus Pharma advances epinephrine nasal spray toward pivotal trial
March 25, 2026 9:00 AM - StreetInsider
Nasus Pharma Advances NS002 Towards Pivotal Study Following Positive Phase 2; Reports Annual Results and Provides Business Update
March 25, 2026 9:00 AM - StreetInsider
Form 6-K Nasus Pharma Ltd For: Mar 16
March 16, 2026 8:02 AM - SEC Filing
Nasus Pharma reports faster epinephrine delivery in phase 2 study
March 16, 2026 7:30 AM - StreetInsider
Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Thera
March 16, 2026 7:30 AM - StreetInsider
Form EFFECT Nasus Pharma Ltd
March 16, 2026 6:13 AM - SEC Filing
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
March 13, 2026 8:35 AM - StreetInsider
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
March 10, 2026 10:22 AM - StreetInsider
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
March 10, 2026 10:21 AM - Globe NewsWire
Nasus Pharma to present NS002 intranasal epinephrine study results
March 9, 2026 8:30 AM - StreetInsider
Nasus Pharma to Present Topline Analysis from NS002 Intranasal Epinephrine Powder Phase 2 Single and Repeat Dose Clinical Study
March 9, 2026 8:30 AM - StreetInsider
Nasus Pharma to Present and Participate in the Upcoming Life Sciences Investor Forum
March 9, 2026 8:00 AM - Globe NewsWire
Nasus Pharma to Present and Participate in the Upcoming Life Sciences Investor Forum
March 9, 2026 8:00 AM - StreetInsider
Full Article List
